MAUREEN TA: Open Payments
NPI 1427497247 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 29 payments from 10 companies in 2025. Trend: 2023 $168 · 2024 $1,042 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $199 |
| Madrigal Pharmaceuticals | 1 | $131 |
| PFIZER INC. | 4 | $85 |
| Janssen Biotech, Inc. | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Organon LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, XELJANZ, ENTYVIO, DUPIXENT, VOQUEZNA, VELSIPITY.
Industry payments across NY — which companies pay providers there.
